These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 38164953

  • 21. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 22. Vascular and renal hemodynamic changes after renal denervation.
    Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.
    Clin J Am Soc Nephrol; 2013 Jul 12; 8(7):1195-201. PubMed ID: 23559677
    [Abstract] [Full Text] [Related]

  • 23. Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention?
    Chen S, Kiuchi MG, Schmidt B, Hoye NA, Acou WJ, Liu S, Chun KRJ, Pürerfellner H.
    Herz; 2019 Aug 12; 44(5):412-418. PubMed ID: 29255910
    [Abstract] [Full Text] [Related]

  • 24. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 25. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    Ott C, Mahfoud F, Schmid A, Ewen S, Toennes SW, Meyer MR, Helfer AG, Maurer HH, Ditting T, Veelken R, Zivanovic I, Uder M, Böhm M, Schmieder RE.
    J Hypertens; 2016 Dec 09; 34(12):2475-2479. PubMed ID: 27607458
    [Abstract] [Full Text] [Related]

  • 26. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    Oliveras A, Armario P, Clarà A, Sans-Atxer L, Vázquez S, Pascual J, De la Sierra A.
    J Hypertens; 2016 Sep 09; 34(9):1863-71. PubMed ID: 27327441
    [Abstract] [Full Text] [Related]

  • 27. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.
    Lambert T, Blessberger H, Gammer V, Nahler A, Grund M, Kerschner K, Buchmayr G, Saleh K, Kammler J, Steinwender C.
    Clin Cardiol; 2014 May 09; 37(5):307-11. PubMed ID: 24700288
    [Abstract] [Full Text] [Related]

  • 28. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
    Scalise F, Sole A, Singh G, Sorropago A, Sorropago G, Ballabeni C, Maccario M, Vettoretti S, Grassi G, Mancia G.
    J Hypertens; 2020 May 09; 38(5):936-942. PubMed ID: 31990900
    [Abstract] [Full Text] [Related]

  • 29. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr 09; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 30. Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
    Rosa J, Widimský P, Waldauf P, Zelinka T, Petrák O, Táborský M, Branny M, Toušek P, Čurila K, Lambert L, Bednář F, Holaj R, Štrauch B, Václavík J, Kociánová E, Nykl I, Jiravský O, Rappová G, Indra T, Krátká Z, Widimský J.
    J Hypertens; 2017 May 09; 35(5):1093-1099. PubMed ID: 28118281
    [Abstract] [Full Text] [Related]

  • 31. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium.
    Blood Press; 2015 May 09; 24(5):263-74. PubMed ID: 26194721
    [Abstract] [Full Text] [Related]

  • 32. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
    Fengler K, Höllriegel R, Okon T, Stiermaier T, Rommel KP, Blazek S, Besler C, von Roeder M, Petzold M, Schuler G, Lurz P.
    J Hypertens; 2017 Jun 09; 35(6):1310-1317. PubMed ID: 28441700
    [Abstract] [Full Text] [Related]

  • 33. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.
    Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238
    [Abstract] [Full Text] [Related]

  • 34. Renal nerve stimulation: complete versus incomplete renal sympathetic denervation.
    Hoogerwaard AF, Adiyaman A, de Jong MR, Smit JJ, Heeg JE, van Hasselt BAAM, Elvan A.
    Blood Press; 2021 Dec 30; 30(6):376-385. PubMed ID: 34647513
    [Abstract] [Full Text] [Related]

  • 35. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S.
    Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375
    [Abstract] [Full Text] [Related]

  • 36. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Böhm M, Mahfoud F, Townsend RR, Kandzari DE, Pocock S, Ukena C, Weber MA, Hoshide S, Patel M, Tyson CC, Weil J, Agdirlioglu T, Fahy M, Kario K.
    Eur Heart J; 2019 Mar 01; 40(9):743-751. PubMed ID: 30608521
    [Abstract] [Full Text] [Related]

  • 37. Renal denervation in hypertensive patients not on blood pressure lowering drugs.
    De Jager RL, Sanders MF, Bots ML, Lobo MD, Ewen S, Beeftink MM, Böhm M, Daemen J, Dörr O, Hering D, Mahfoud F, Nef H, Ott C, Saxena M, Schmieder RE, Schlaich MP, Spiering W, Tonino PA, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Worthley SG, Blankestijn PJ.
    Clin Res Cardiol; 2016 Sep 01; 105(9):755-62. PubMed ID: 27105858
    [Abstract] [Full Text] [Related]

  • 38. Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes.
    Al Ghorani H, Kulenthiran S, Lauder L, Recktenwald MJM, Dederer J, Kunz M, Götzinger F, Ewen S, Ukena C, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2024 Oct 01; 113(10):1384-1392. PubMed ID: 38451261
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
    Wang J, Yin Y, Lu C, Lu Z, Hu J, Wang Y, Ge J, Jiang H, Yao C, Yan X, Ma W, Qi X, Dang Y, Chen S, Zhu J, Wang D, Ding C, Wang W, Liu J, Wang Y, Li H, Pan Z, Cui K, Li C, Liang X, Chen W, Sobotka PA, Zhang J, Esler M, Sun N, Chen M, Huo Y.
    EClinicalMedicine; 2024 Jun 01; 72():102626. PubMed ID: 38756107
    [Abstract] [Full Text] [Related]

  • 40. Feasibility of catheter ablation renal denervation in "mild" resistant hypertension.
    Chen S, Kiuchi MG, Acou WJ, Derndorfer M, Wang J, Li R, Kollias G, Martinek M, Kiuchi T, Pürerfellner H, Liu S.
    J Clin Hypertens (Greenwich); 2017 Apr 01; 19(4):361-368. PubMed ID: 28266770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.